CanadaWhat's being recalled
Depth of recall: Retailers
Companies: Sandoz Canada Incorporated, 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, J3Z 1G5.
How to identify it
Brand: Sandoz Canada; Product Name: Sandoz Lisinopril HCT; Market Authorization: DIN 02302381; Dosage Form: Tablet; Strength: HYDROCHLOROTHIAZIDE 25 MG LISINOPRIL (LISINOPRIL DIHYDRATE) 20 MG; Lot: PJ5263 PJ5264
The hazard
Affected lots were recalled following assay stability out-of-specification test results.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)